Detalhe da pesquisa
1.
Peripheral helper T cells in the pathogenesis of multiple sclerosis.
Mult Scler
; 28(9): 1340-1350, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35112578
2.
Dimethyl fumarate therapy suppresses B cell responses and follicular helper T cells in relapsing-remitting multiple sclerosis.
Mult Scler
; 25(9): 1289-1297, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30043661
3.
Dimethyl fumarate treatment of primary progressive multiple sclerosis: results of an open-label extension study.
Mult Scler Relat Disord
; 70: 104458, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36586351
4.
Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis.
Mult Scler Relat Disord
; 68: 104209, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36257152
5.
Increased Intrathecal Activity of Follicular Helper T Cells in Patients With Relapsing-Remitting Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
; 9(5)2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35835563
6.
Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis: A Randomized, Controlled Trial.
Neurol Neuroimmunol Neuroinflamm
; 8(5)2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34429340
7.
Dimethyl fumarate therapy reduces memory T cells and the CNS migration potential in patients with multiple sclerosis.
Mult Scler Relat Disord
; 37: 101451, 2020 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-31675639
8.
Progressive multiple sclerosis, cognitive function, and quality of life.
Brain Behav
; 8(2): e00875, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29484253